SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (168)12/6/1996 5:25:00 AM
From: Julie Suk   of 1762
 
Hello Bennett

Idec is very knowledable on making humanized antibodies at large scales at very low cost. Though I only met with Idec once, I speak as a PhD process design engineer with 10 years experience in this field.


As a stock picker, I had a marvelous loosing streak, i.e. synergen (42 to 14 in one morning,Boulder Colorado, septic shock) and Somatogen (also Boulder Colorado). However, my husband (he is not a knowlegeable process engineer) suggested Centocor when it was 5 (also septic shock) and ever since then we have been generally in the right direction.

Julie
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News